Lars Erik Vølund Kristensen

Lars Erik Vølund Kristensen

Clinical Professor


Publication year:
All
1 - 3 out of 3Page size: 10
  1. 2024
  2. E-pub ahead of print

    Adherence to therapy of ixekizumab and secukinumab in psoriatic arthritis patients using first- or second-line IL-17A inhibitor treatment: A Danish population-based cohort study

    Hansen, R. L., Jørgensen, T. S., Egeberg, Alexander, Rosenø, N. A. L., Skougaard, M., Stisen, Z. R., Dreyer, L. & Kristensen, Lars Erik Vølund, 2024, (E-pub ahead of print) In: Rheumatology (Oxford, England).

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Changes in Inflammatory Cytokines in Responders and Non-Responders to TNFα Inhibitor and IL-17A Inhibitor: A Study Examining Psoriatic Arthritis Patients

    Skougaard, M., Søndergaard, M. F., Ditlev, S. B. & Kristensen, Lars Erik Vølund, 2024, In: International Journal of Molecular Sciences. 25, 5, 15 p., 3002.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. E-pub ahead of print

    Tolerability and comparative effectiveness of TNF-, IL-17-, and IL-23(p19) inhibitors in psoriatic arthritis: A target trial emulation study

    Stisen, Z. R., Nielsen, S. M., Skougaard, M., Mogensen, Mette, Jørgensen, T. S., Dreyer, L., de Wit, M., Christensen, R. & Kristensen, Lars Erik Vølund, 2024, (E-pub ahead of print) In: Rheumatology (Oxford, England).

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 164256855